Dr. Charalambos (Babis) Andreadis specializes in adult bone marrow transplantation (BMT) and the treatment of Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He is certified by the American Board of Internal Medicine in hematology, medical oncology and internal medicine. His research, published widely in medical and scientific journals, addresses the clinical and genetic determinants of response to therapy and toxicity, and patient outcomes in these disorders.  

Andreadis earned a medical degree at Columbia University's College of Physicians and Surgeons and was elected to Alpha Omega Alpha in 1998. He completed a residency in medicine at the New York-Presbyterian Hospital and a fellowship in the division of hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. Andreadis earned a master's degree in clinical epidemiology, with a focus on pharmacogenetics, at the University of Pennsylvania. He is an assistant clinical professor of medicine at UCSF and a member of the UCSF Helen Diller Family Comprehensive Cancer Center.